Zhang X, Rao M, Xu G
Arch Med Sci. 2024; 20(2):494-505.
PMID: 38757021
PMC: 11094828.
DOI: 10.5114/aoms/152174.
Li Z, Liu J, Sun X, Li Y
Heliyon. 2024; 10(6):e27861.
PMID: 38533073
PMC: 10963323.
DOI: 10.1016/j.heliyon.2024.e27861.
Omatsu Y
Inflamm Regen. 2023; 43(1):15.
PMID: 36805714
PMC: 9942337.
DOI: 10.1186/s41232-023-00267-5.
Riese J, Hahnel C, Menz J, Hannemann M, Khabipov A, Luhrs F
Front Immunol. 2022; 13:1053490.
PMID: 36532028
PMC: 9755867.
DOI: 10.3389/fimmu.2022.1053490.
Bertolini G, Roato I
Bone Rep. 2022; 17:101619.
PMID: 36110341
PMC: 9467890.
DOI: 10.1016/j.bonr.2022.101619.
NF-κB Inducing Kinase Regulates Intestinal Immunity and Homeostasis.
Wang B, Shen J
Front Immunol. 2022; 13:895636.
PMID: 35833111
PMC: 9271571.
DOI: 10.3389/fimmu.2022.895636.
Mapping the developing human immune system across organs.
Suo C, Dann E, Goh I, Jardine L, Kleshchevnikov V, Park J
Science. 2022; 376(6597):eabo0510.
PMID: 35549310
PMC: 7612819.
DOI: 10.1126/science.abo0510.
Deletion of in -Expressing Cells Causes Microenvironmental Impairment of B Cell Lymphopoiesis.
Chicana B, Abbasizadeh N, Burns C, Taglinao H, Spencer J, Manilay J
Front Immunol. 2022; 13:780945.
PMID: 35250971
PMC: 8889104.
DOI: 10.3389/fimmu.2022.780945.
Multifaceted role of chemokines in solid tumors: From biology to therapy.
Raza S, Rajak S, Tewari A, Gupta P, Chattopadhyay N, Sinha R
Semin Cancer Biol. 2022; 86(Pt 3):1105-1121.
PMID: 34979274
PMC: 7613720.
DOI: 10.1016/j.semcancer.2021.12.011.
Immune Checkpoint Inhibitor Therapy for Bone Metastases: Specific Microenvironment and Current Situation.
Liu C, Wang M, Xu C, Li B, Chen J, Chen J
J Immunol Res. 2021; 2021:8970173.
PMID: 34877360
PMC: 8645368.
DOI: 10.1155/2021/8970173.
Rituximab- and ocrelizumab-induced early- and late-onset neutropenia in a multiple sclerosis patient.
Marrodan M, Laviano J, Oneto S, Reino F, Delorme R, Fornillo F
Neurol Sci. 2021; 42(9):3893-3895.
PMID: 34075515
DOI: 10.1007/s10072-021-05357-1.
The biological role of the CXCL12/CXCR4 axis in esophageal squamous cell carcinoma.
Wu X, Zhang H, Sui Z, Wang Y, Yu Z
Cancer Biol Med. 2021; .
PMID: 33710803
PMC: 8185864.
DOI: 10.20892/j.issn.2095-3941.2020.0140.
Toward Therapeutic Targeting of Bone Marrow Leukemic Niche Protective Signals in B-Cell Acute Lymphoblastic Leukemia.
Delahaye M, Salem K, Pelletier J, Aurrand-Lions M, Mancini S
Front Oncol. 2021; 10:606540.
PMID: 33489914
PMC: 7820772.
DOI: 10.3389/fonc.2020.606540.
Impact of 2 Gy γ-irradiation on the hallmark characteristics of human bone marrow-derived MSCs.
Iwasa M, Fujii S, Fujishiro A, Maekawa T, Andoh A, Takaori-Kondo A
Int J Hematol. 2021; 113(5):703-711.
PMID: 33386593
DOI: 10.1007/s12185-020-03072-9.
Coexpression of CCR7 and CXCR4 During B Cell Development Controls CXCR4 Responsiveness and Bone Marrow Homing.
Mcheik S, Van Eeckhout N, De Poorter C, Gales C, Parmentier M, Springael J
Front Immunol. 2020; 10:2970.
PMID: 31921208
PMC: 6930800.
DOI: 10.3389/fimmu.2019.02970.
The -Axis Is of Prognostic Relevance in DLBCL and Its Antagonists Exert Pro-Apoptotic Effects In Vitro.
Pansy K, Feichtinger J, Ehall B, Uhl B, Sedej M, Roula D
Int J Mol Sci. 2019; 20(19).
PMID: 31554271
PMC: 6801866.
DOI: 10.3390/ijms20194740.
Updates on Osteoimmunology: What's New on the Cross-Talk Between Bone and Immune System.
Ponzetti M, Rucci N
Front Endocrinol (Lausanne). 2019; 10:236.
PMID: 31057482
PMC: 6482259.
DOI: 10.3389/fendo.2019.00236.
Cell circuits and niches controlling B cell development.
Zehentmeier S, Pereira J
Immunol Rev. 2019; 289(1):142-157.
PMID: 30977190
PMC: 6464388.
DOI: 10.1111/imr.12749.
The NOTCH Pathway and Its Mutations in Mature B Cell Malignancies.
Arruga F, Vaisitti T, Deaglio S
Front Oncol. 2018; 8:550.
PMID: 30534535
PMC: 6275466.
DOI: 10.3389/fonc.2018.00550.
Murine Bone Marrow Niches from Hematopoietic Stem Cells to B Cells.
Aurrand-Lions M, Mancini S
Int J Mol Sci. 2018; 19(8).
PMID: 30103411
PMC: 6121419.
DOI: 10.3390/ijms19082353.